<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <source-app name="Horizon">Horizon</source-app>
      <rec-number>1</rec-number>
      <foreign-keys>
        <key app="Horizon" db-id="PAR00005532">1</key>
      </foreign-keys>
      <ref-type name="Journal Article">17</ref-type>
      <work-type>ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES</work-type>
      <contributors>
        <authors>
          <author>
            <style face="normal" font="default" size="100%">Cressey, Tim R.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Plipat, Nottasorn</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Fregonese, Federica</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Chokephaibulkit, Kulkanya</style>
          </author>
        </authors>
      </contributors>
      <titles>
        <title>Indinavir/ritonavir remains an important component of HAART for the treatment of HIV/AIDS, particularly in resource-limited settings</title>
        <secondary-title>Expert Opinion on Drug Metabolism &amp; Toxicology</secondary-title>
      </titles>
      <pages>347-361</pages>
      <dates>
        <year>2007</year>
      </dates>
      <call-num>PAR00005532</call-num>
      <language>ENG</language>
      <periodical>
        <full-title>Expert Opinion on Drug Metabolism &amp; Toxicology</full-title>
      </periodical>
      <isbn>1742-5255</isbn>
      <accession-num>ISI:000247483500004</accession-num>
      <number>3</number>
      <urls>
        <related-urls>
          <url>https://www.documentation.ird.fr/hor/PAR00005532</url>
        </related-urls>
      </urls>
      <volume>3</volume>
      <remote-database-provider>Horizon (IRD)</remote-database-provider>
      <custom1>UR174</custom1>
      <custom7>Thaïlande</custom7>
    </record>
  </records>
</xml>
